Many Canadians living with asthma are experiencing poor control over their symptoms, impacting the workplace, said Anjila Arora, director of pharmaceutical benefits at Sun Life Financial Inc., during Benefits Canada’s 2023 Face to Face Drug Plan Management Forum. Between 53 and 90 per cent of asthmatic Canadians meet at least one criteria for poor control […]
Half (51 per cent) of Canadian benefits plan members say they understand their plan extremely or very well, down from 65 per cent in 2018, according to the 2023 Benefits Canada Healthcare Survey. It found plan members’ top sources for information about their benefits plan were websites (69 per cent), followed at some distance by […]
More than half (54 per cent) of Canadian benefits plan members currently live with at least one diagnosed chronic health condition, according to the 2023 Benefits Canada Healthcare Survey. It found the top current diagnoses were a mental-health condition such as depression or anxiety (18 per cent), high cholesterol (12 per cent), arthritis (12 per […]
Three main drug categories — diabetes, asthma and stimulants for attention deficit hyperactivity disorder — accounted for rising drug claims in 2022, according to Lavina Viegas, Telus Health’s director of client account management, speaking during Benefits Canada‘s 2023 Benefits & Pension Summit in June. Referring to Telus Health’s 2023 drug plan trends report, she said […]
Specialty drugs are accounting for a slightly smaller portion of the total eligible amount for all drug claims, declining from 33.6 per cent in 2021 to 33.1 per cent in 2022, according to Telus Health’s annual drug trends report. The report, based on claims data from more than 4.6 million plan members in 2022, found the […]
Approximately three million Canadians live with asthma, a chronic inflammatory disease that affects airways, limits airflow and makes breathing difficult, said Dr. Erika Penz, associate professor in respirology, critical care and sleep medicine at the University of Saskatchewan, during a webinar hosted by Benefits Canada and sponsored by GSK in November. Asthma, which affects people of […]
A majority (88 per cent) of benefits plan sponsors are very (34 per cent) or somewhat (54 per cent) satisfied with their organization’s virtual health-care offerings, up from nearly three-quarters (74 per cent) in 2021, according to the 2022 Benefits Canada Healthcare Survey. More than a quarter of plan sponsors (29 per cent) and plan […]
Severe asthma is a complex condition that impacts between 150,000 and 250,000 Canadians, according to Vanessa Foran, president and chief executive officer of Asthma Canada, during a webinar hosted last month by Benefits Canada and supported by AstraZeneca. It’s an acute condition where people have difficulty achieving control of their disease despite proper use of […]